Sean Maduke

Equibles does not estimate personal net worth.

Get an email with a short summary when Corcept Therapeutics Inc publishes a filing, an earnings call transcript or a press release.

Get CORT alerts

About Sean Maduke

Sean Maduke has spoken on 1 earnings call across 1 company, most recently for Corcept Therapeutics Inc on July 31, 2025. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), James N. Wilson (Chairman and Board Member), Atabak Mokari (CFO) and 7 others.

Sean Maduke on recent calls

“The endocrinology division had an excellent second quarter. For the sixth quarter in a row, we added a record number of new prescribers and new prescriptions, and there are a record number of patients on therapy.”

Other, Corcept Therapeutics Inc Q2 FY2025 Earnings Call · July 31, 2025

Affiliation history

Corcept Therapeutics Inc (CORT)
Transcript header (unverified)

Current

Company network

Corcept Therapeutics Inc

CORT

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2025-07-31

View calls and events

Leadership on record at Corcept Therapeutics Inc

Joseph K. Belanoff CEO, Board Member
James N. Wilson Chairman, Board Member
Atabak Mokari CFO
Joshua M. Murray CFO, Head of Investor Relations, Board Member
Daniel N. Swisher COO
J.D. Lyon Chief Accounting Officer
Joseph D. Lyon Chief Accounting Officer
Daniel N. Swisher, Jr. Board Member
David L. Mahoney Board Member
G. Leonard Baker, Jr. Board Member

Recent activity

Earnings call Corcept Therapeutics Inc Q2 FY2025 Earnings Call Corcept Therapeutics Inc (CORT)
2025-07-31